Cholinergic Basis for Alzheimer Therapy

Booknews

This first publication in the Advances in Alzheimer therapy series is a comprehensive overview of the state of knowledge and practice in the development of cholinergic therapies in Alzheimer's disease, including cholinesterase inhibitors, muscarinic and nicotinic agents, and neuromodulators. The use of nerve growth factor(s) is also discussed by several specialists. For researchers and practitioners interested in the clinical potential of drug therapies using this approach for patients with Alzheimer's disease. Annotation c. Book News, Inc., Portland, OR (booknews.com)